Official Title: A Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study

https://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-announces-topline-data-phase-2-peninsula-trial

BofA upgraded BioCryst (BCRX) to Buy from Neutral with a

Official Title: A Proof-of-concept, Randomized, Double-blind, Placebo-controlled, Phase 2a Study

Official Title: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to